Email this article LACTOFERRIN, FLUORESCENT TECHNOLOGIES AND THEIR ROLE IN THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY DISEASES OF THE FEMALE SEXUAL SPHERE
- Authors: Zuev V.M1, Gulenkova D.G1, Goldman I.L2, Sadchikova E.R2, Aleksandrov M.T1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University, V.F. Snegirev Clinic of Obstetrics and Gynecology
- Institute of Gene Biology
- Issue: Vol 5, No 2 (2018)
- Pages: 101-105
- Section: Original study articles
- URL: https://journals.rcsi.science/2313-8726/article/view/35468
- DOI: https://doi.org/10.18821/2313-8726-2018-5-2-101-105
- ID: 35468
Cite item
Full Text
Abstract
The article reflects a modern view on the introduction of fluorescent methods of diagnostics and treatment of vaginal infections using lactoferrin in clinical microbiology, which made it possible to expand microecological studies. The suppression of the normal vaginal microflora was shown to promote a diverse pathology of both inflammatory and non-inflammatory genesis. Bacterial and fungal vaginosis were proved to be the most important risk factors for the development of infectious complications in the gynecological practice. There are given substantiated scientific evidence, indicating a large number of recurrences of bacterial and candidal vaginitis, despite the numerous studies and various treatment options. The relationship of bacterial vaginitis with infertility, the threat of miscarriage, premature birth, intrauterine infection of the fetus, etc. was established. Based on this, the search for alternative combined methods is relevant. The aim of the study was to increase the effectiveness of the treatment of recurrent candid vulvovaginitis and bacterial vaginosis by using lactoferrin. In the study, there were used fluorescent methods of the diagnosis, which made it possible to verify the diagnosis in the rapid assessment mode, as well as monitor treatment and improve its effectiveness.
Full Text
##article.viewOnOriginalSite##About the authors
V. M Zuev
I.M. Sechenov First Moscow State Medical University, V.F. Snegirev Clinic of Obstetrics and Gynecology119045, Moscow, Russian Federation
D. G Gulenkova
I.M. Sechenov First Moscow State Medical University, V.F. Snegirev Clinic of Obstetrics and Gynecology119045, Moscow, Russian Federation
I. L Goldman
Institute of Gene BiologyMoscow, 119334, Russian Federation
E. R Sadchikova
Institute of Gene BiologyMoscow, 119334, Russian Federation
M. T Aleksandrov
I.M. Sechenov First Moscow State Medical University, V.F. Snegirev Clinic of Obstetrics and Gynecology119045, Moscow, Russian Federation
References
- Буданов П.В. Эффективное восстановление колонизационной резистентности влагалища: преимущества и ограничения вагинальных лекарственных форм. Вопросы гинекол., акуш. и перинатол. 2013; 12 (2): 72-8.
- Кудрявцева Л.В., Ильина Л.В., Говорун В.М. и др. Бактериальный вагиноз (пособие для врачей). М.; 2005: 48-50.
- Кулаков В.И. Репродуктивное здоровье населения Poccии. Consilium Med. 2007; (2): 26.
- Бодяжина В.И., Сметник В.П., Тумилович Л.Г. Неоперативная гинекология. М.: Медицина; 1990.
- Houghton M.R., Gracey M., Burke V., Bottrell C., Spargo R.M. Breast milk lactoferrin levels in relation to maternal nutritional status. J. Pediatr. Gastroenterol. Nutr. 1985; 4: 230-5.
- Прилепская В.Н., Байрамова Г.Р. Нарушение микробиоценоза влагалища, пути его коррекции. Гинекология. 2007; 9 (4): 25-7.
- Прилепская В.Н., Довлетханова Э.Р., Байрамова Г.Р. Современный взгляд на вопросы этиологии, патогенеза и лечения бактериального вагиноза. Гинекология. 2010; 2 (12): 44-9.
- Legrand D., Elass E., Carpentier M., Mazurie J. Lactoferrin structure and functions. Adv. Exp. Med. Biol. 2008; 606: 163-94. doi: 10.1007/978-0-387-74087-4_6.
- Радзинский В.Е., Ордиянц И.М. Двухэтапная терапия вагинальных инфекций. М.: StatusPraesens; 2012.
- Руднева О.Д., Добрецова Т.А., Маклецова С.А. Рецидивы баквагиноза и лактофлора: от актуальной неоднозначности к практическим решениям. Под ред. В.Е. Радзинского. М.: StatusPraesens; 2013: 16-8.
- Савичева А.М., Балан В.Е., Роговская С.И. Бактериальный вагиноз: от новых трендов науки к практическим решениям. Медицинские аспекты здоровья женщины. 2014; 79 (4): 47-52.
- Чеботарь И.В., Маянский А.Н., Кончакова Е.Д. и др. Антибиотикорезистентность биоплёночных бактерий. Клин. микробиология и антимикробная химиотерапия. 2012; 14 (1): 51-8.
- Юдина М.А., Гречканев Г.О., Чандра-Д`Мелло Р. Оптимизация лечения бактериального вагиноза. Медицинский альманах. 2012; (5): 292-6.
- Юдина М.А., Гречканев Г.О., Гаревская Ю.А. Сравнительный анализ эффективности различных методов лечения бактериального вагиноза. Медицинский альманах. 2014; (2): 81-4.
- Gonzalez-Chavez S.A., Arevalo-Gallegos S., Rascon-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents. 2009; 33(4): 301.e1-8. doi: 10.1016/j.ijantimicag.2008.07.020.
- Masson P.L., Heremans J.F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 1969; 130: 643-58.
- Montreuil J., Tonnelat J., Mullet S. Preparation et proprietes de la lactosiderophiline (lactotransferrine) du lait de femme. Biochim. Biophys. Acta. 1960; 45: 413-21.
- Yuan Q., Zhuo C., Yonggui M., Fuer L., Suhua C., Guangying H. Nonoxynol-9 berberine plural gel has little effect on expression of SLPI, SP-D and lactoferrin in mice’s vagina. Iran. J. Reprod. Med. 2013;11(7): 565-76.
- Teng C.T., Beard C., Gladwell W. Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat and hamster. Biol. Reprod. 2002; 67: 1439-49.
- Yanaihara A., Mitsukawa K., Iwasaki Sh., Otsuki K., Kawamura T., Okai T. High concentrations of lactoferrin in the follicular fluid correlate with embryo quality during in vitro fertilization cycles. Fertil. Steril. 2007; 87: 279-82.
Supplementary files
